BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ji Y, Cao H, Liu Q, Li Z, Song H, Xu D, Tian D, Qiu B, Wang J. Screening for pulmonary tuberculosis in high-risk groups of diabetic patients. Int J Infect Dis 2020;93:84-9. [PMID: 31978585 DOI: 10.1016/j.ijid.2020.01.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Wu Q, Liu Y, Ma YB, Liu K, Chen SH. Incidence and prevalence of pulmonary tuberculosis among patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Med 2022;54:1657-66. [PMID: 35703920 DOI: 10.1080/07853890.2022.2085318] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Jerene D, Muleta C, Dressie S, Ahmed A, Tarekegn G, Haile T, Bedru A, Mustapha G, Gebhard A, Wares F. The yield of chest X-ray based versus symptom-based screening among patients with diabetes mellitus in public health facilities in Addis Ababa, Ethiopia. J Clin Tuberc Other Mycobact Dis 2022;29:100333. [PMID: 36238947 DOI: 10.1016/j.jctube.2022.100333] [Reference Citation Analysis]
3 Qiao J, Tan Z, Xu X, Zhou Y, Wang W, Luo J, Fan J, Pan Q, Guo L. Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study. Front Endocrinol 2022;13:980982. [DOI: 10.3389/fendo.2022.980982] [Reference Citation Analysis]
4 Naufal F, Chaisson LH, Robsky KO, Delgado-Barroso P, Alvarez-Manzo HS, Miller CR, Shapiro AE, Golub JE. Number needed to screen for TB in clinical, structural or occupational risk groups. Int J Tuberc Lung Dis 2022;26:500-8. [PMID: 35650693 DOI: 10.5588/ijtld.21.0749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Salifu RS, Hlongwa M, Hlongwana K. Implementation of the WHO's collaborative framework for the management of tuberculosis and diabetes: a scoping review. BMJ Open 2021;11:e047342. [PMID: 34789489 DOI: 10.1136/bmjopen-2020-047342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Alsdurf H, Empringham B, Miller C, Zwerling A. Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review. BMC Infect Dis 2021;21:935. [PMID: 34496804 DOI: 10.1186/s12879-021-06633-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Mohd Hassan NZA, Razali A, Shahari MR, Mohd Nor Sham Kunusagaran MSJ, Halili J, Zaimi NA, Bahari MS, Aminuddin F. Cost-Effectiveness Analysis of High-Risk Groups Tuberculosis Screening in Malaysia. Front Public Health 2021;9:699735. [PMID: 34322473 DOI: 10.3389/fpubh.2021.699735] [Reference Citation Analysis]
8 Jacob S, George LS, Joy A, Mathew MM, Vijayakumar K, Kumar A, Kunoor A. Prevalence of diabetes mellitus and HIV/AIDS among tuberculosis patients in Kerala. J Family Med Prim Care 2020;9:6209-12. [PMID: 33681065 DOI: 10.4103/jfmpc.jfmpc_1583_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 van Crevel R, Critchley JA. The Interaction of Diabetes and Tuberculosis: Translating Research to Policy and Practice. Trop Med Infect Dis 2021;6:8. [PMID: 33435609 DOI: 10.3390/tropicalmed6010008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
10 Qiu B, Liu Q, Li Z, Song H, Xu D, Ji Y, Jiang Y, Tian D, Wang J. Evaluation of cytokines as a biomarker to distinguish active tuberculosis from latent tuberculosis infection: a diagnostic meta-analysis. BMJ Open 2020;10:e039501. [PMID: 33033030 DOI: 10.1136/bmjopen-2020-039501] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]